ArticleACS applied materials & interfaces2025
Microfluidic 3D Bioprinting of Foamed Fibers with Controlled Micromorphology.
Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Aqueous Two-Phase Bioinks for Discrete Packing and Compartmentalization of 3D Bioprinted Cells.Advanced healthcare materials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The synergistic integration of microfluidic technologies with additive manufacturing systems is advancing the development of innovative platforms to 3D bioprint scaffolds for tissue engineering with unparalleled biological relevance. Significant interest is growing in realizing porous functionally graded materials (pFGMs) that can resemble the hierarchical organization of porosity found in bone tissue. This study introduces a method for fabricating porous scaffolds based on the real-time generation of a liquid foam, which is gelled, forming porous fibers that are organized into structured matrixes using a 3D bioprinting system. The primary advantage of this approach is the possibility to adjust bubble size during printing dynamically, modifying the characteristics of the deposited foamed filaments online and in one step. As a result, locally-defined and tailor-made pores can be distributed in 3D structures with high spatial accuracy. Besides the mechanical and morphological characterization of diverse microarchitectures, we also explored the biocompatibility of the proposed approach by directly embedding osteosarcoma cells within the biomaterial. Results demonstrated the biocompatibility of the proposed methodology and revealed the influence of the interior microporosity on cell proliferation, highlighting the potential for creating tailored tissue microenvironments. The findings underscore the versatility of the presented 3D bioprinting system and its potential in fabricating biomimetic scaffolds with tailored morphological gradients, representing a substantial advancement in pFGM synthesis, with direct implications in regenerative medicine and tissue engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.